A Study of Apatinib Treatment in for Advanced Ovarian Cancer

NCT03393507 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Chemotherapeutic Toxicity

Interventions

DRUG: Apatinib
DRUG: Taxus + platinum

Sponsor

The People's Hospital of Leshan

Collaborators

[object Object]